Cancers | 2025 Editor’s Choice Articles and Special Issues Related to Cancer Biomarkers
Editor's Choice Articles are selected based on suggestions from Cancers’ Academic Editors worldwide. The Editors select a small number of recently published articles that they consider particularly interesting to our readers or important in their respective fields of research. You are welcome to read the 2025 Editor’s Choice Articles and Special Issues related to cancer biomarkers. The full list of Editor's Choice Articles can be viewed at the following link: https://www.mdpi.com/journal/cancers/editors_choice.
The list of relevant papers can be seen below:
“Methylation Analyses in Liquid Biopsy of Lung Cancer Patients: A Novel and Intriguing Approach Against Resistance to Target Therapies and Immunotherapies”
by Domenico Trombetta, Marco Donatello Delcuratolo, Federico Pio Fabrizio, Francesco Delli Muti, Antonio Rossi, Antonella Centonza, Francesco Pio Guerra, Angelo Sparaneo, Michele Piazzolla, Paola Parente et al.
Cancers 2025, 17(18), 3021; https://doi.org/10.3390/cancers17183021
Available online: https://www.mdpi.com/2072-6694/17/18/3021
“Immune Biomarkers for Checkpoint Blockade in Solid Tumors: Transitioning from Tissue to Peripheral Blood Monitoring and Future Integrated Strategies”
by Ioannis P. Trontzas and Konstantinos N. Syrigos
Cancers 2025, 17(16), 2639; https://doi.org/10.3390/cancers17162639
Available online: https://doi.org/10.3390/cancers17162639
“Repurposing the Tyrosine Kinase Inhibitors Targeting FGFR and VEGFR Pathways for Cancer Therapy: A Comprehensive Review”
by Sergei Boichuk and Tatyana Gessel
Cancers 2025, 17(20), 3354; https://doi.org/10.3390/cancers17203354
Available online: https://www.mdpi.com/2072-6694/17/20/3354
“Decision-Making Biomarkers Guiding Therapeutic Strategies in Hepatocellular Carcinoma: From Prediction to Personalized Care”
by Dongming Liu and Norihiro Imai
Cancers 2025, 17(19), 3105; https://doi.org/10.3390/cancers17193105
Available online: https://www.mdpi.com/2072-6694/17/19/3105
“Bridging Discovery and Treatment: Cancer Biomarker”
by Hengrui Liu, Ilayda Karsidag, Rebecca Golin and Guangzhen Wu
Cancers 2025, 17(22), 3720; https://doi.org/10.3390/cancers17223720
Available online: https://www.mdpi.com/2072-6694/17/22/3720
“The Role of Epigenetic Biomarkers as Diagnostic, Predictive and Prognostic Factors in Colorectal Cancer”
by Zuzanna Chilimoniuk, Konrad Gładysz, Natalia Moniczewska, Katarzyna Chawrylak, Zuzanna Pelc and Radosław Mlak
Cancers 2025, 17(16), 2632; https://doi.org/10.3390/cancers17162632
Available online: https://www.mdpi.com/2072-6694/17/16/2632
Special Issues:
“Liquid Biopsy Innovation: From ctDNA to RNA Modifications in Genitourinary Cancers”
Guest Editors: Dr. Edoardo Francini, Dr. Giuseppe Fanelli and Dr. Jacopo Venturini
Submission deadline: 31 August 2026
“Emerging Biomarkers for Precision Oncology in Gastrointestinal Cancers”
Guest Editor: Dr. Alessandro Ottaiano
Submission deadline: 1 October 2026
“Advancing Precision Oncology: From Biomarker Discovery to Clinical Validation”
Guest Editors: Prof. Dr. Manoj Pandey and Dr. Ruhi Dixit
Submission deadline: 20 October 2026
“Emerging Biomarkers for Immune Checkpoint Inhibitor Sensitivity and Resistance in Non-Small-Cell Lung Cancer”
Guest Editor: Dr. Minglei Zhuo
Submission deadline: 20 April 2027
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office